Patricia Nasshorn - 15 Dec 2021 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Chief Business Officer
Signature
/s/ Patricia Nasshorn by Kerri-Ann Millar, attorney-in-fact
Issuer symbol
CUE
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
3
Filing time
04 Jan 2022, 15:58:56 UTC
Next filing
29 Mar 2022
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.